Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | MRNA |
---|---|---|
09:32 ET | 64903 | 139.02 |
09:34 ET | 34244 | 139.63 |
09:36 ET | 31660 | 140.08 |
09:38 ET | 9943 | 139.5009 |
09:39 ET | 3040 | 140.175 |
09:41 ET | 12670 | 141.095 |
09:43 ET | 10655 | 141.39 |
09:45 ET | 30992 | 142.02 |
09:48 ET | 25092 | 141.205 |
09:50 ET | 22599 | 140.22 |
09:52 ET | 23622 | 139.675 |
09:54 ET | 7219 | 139.91 |
09:56 ET | 6354 | 140.04 |
09:57 ET | 4814 | 140.0967 |
09:59 ET | 12189 | 139.345 |
10:01 ET | 3165 | 139.46 |
10:03 ET | 7155 | 139.56 |
10:06 ET | 3074 | 139.65 |
10:08 ET | 7523 | 139.75 |
10:10 ET | 4238 | 140.055 |
10:12 ET | 8868 | 139.77 |
10:14 ET | 5564 | 139.82 |
10:15 ET | 6806 | 139.68 |
10:17 ET | 2849 | 139.83 |
10:19 ET | 4225 | 139.7906 |
10:21 ET | 3570 | 139.41 |
10:24 ET | 3889 | 139.3439 |
10:26 ET | 15685 | 139.04 |
10:28 ET | 3807 | 139.05 |
10:30 ET | 5121 | 139.03 |
10:32 ET | 3250 | 139.27 |
10:33 ET | 3251 | 139.21 |
10:35 ET | 9879 | 138.9765 |
10:37 ET | 8604 | 138.8418 |
10:39 ET | 4530 | 139.12 |
10:42 ET | 12564 | 138.96 |
10:44 ET | 25551 | 138.4031 |
10:46 ET | 13968 | 138.34 |
10:48 ET | 10760 | 138.27 |
10:50 ET | 3716 | 138.51 |
10:51 ET | 3734 | 138.8 |
10:53 ET | 15564 | 138.723 |
10:55 ET | 8561 | 139.04 |
10:57 ET | 5213 | 139.14 |
11:00 ET | 10755 | 139.11 |
11:02 ET | 5149 | 139.14 |
11:04 ET | 4360 | 138.69 |
11:06 ET | 1632 | 138.87 |
11:08 ET | 2880 | 139.01 |
11:09 ET | 5254 | 139.545 |
11:11 ET | 5053 | 139.5 |
11:13 ET | 2177 | 139.4 |
11:15 ET | 4383 | 139.44 |
11:18 ET | 2569 | 139.01 |
11:20 ET | 2894 | 139.185 |
11:22 ET | 918 | 139.03 |
11:24 ET | 907 | 139.16 |
11:26 ET | 2597 | 139.11 |
11:27 ET | 1091 | 139.11 |
11:29 ET | 3008 | 139.1481 |
11:31 ET | 3520 | 139.06 |
11:33 ET | 3244 | 138.8 |
11:36 ET | 4867 | 139 |
11:38 ET | 2391 | 138.8477 |
11:40 ET | 3237 | 138.89 |
11:42 ET | 1520 | 139.02 |
11:44 ET | 5082 | 138.89 |
11:45 ET | 1218 | 138.97 |
11:47 ET | 2368 | 139.24 |
11:49 ET | 1530 | 139.12 |
11:51 ET | 3628 | 139.11 |
11:54 ET | 2154 | 139.215 |
11:56 ET | 4204 | 139.2081 |
11:58 ET | 600 | 139.16 |
12:00 ET | 3380 | 139.025 |
12:02 ET | 2169 | 139.17 |
12:03 ET | 4221 | 139.27 |
12:05 ET | 6929 | 139.4902 |
12:07 ET | 2455 | 139.585 |
12:09 ET | 2520 | 139.72 |
12:12 ET | 5551 | 139.9 |
12:14 ET | 3716 | 140.1 |
12:16 ET | 1900 | 140.04 |
12:18 ET | 4152 | 140.1 |
12:20 ET | 11105 | 140.17 |
12:21 ET | 587 | 140.27 |
12:23 ET | 3904 | 140.33 |
12:25 ET | 4136 | 140.33 |
12:27 ET | 5389 | 140.35 |
12:30 ET | 3648 | 140.35 |
12:32 ET | 1305 | 140.4501 |
12:34 ET | 5036 | 140.41 |
12:36 ET | 14339 | 140.59 |
12:38 ET | 6587 | 140.84 |
12:39 ET | 8524 | 140.91 |
12:41 ET | 3650 | 140.7 |
12:43 ET | 8351 | 140.61 |
12:45 ET | 4593 | 140.5169 |
12:48 ET | 3912 | 140.76 |
12:50 ET | 6166 | 140.535 |
12:52 ET | 8851 | 140.42 |
12:54 ET | 2651 | 140.5 |
12:56 ET | 2203 | 140.46 |
12:57 ET | 3386 | 140.29 |
12:59 ET | 53943 | 140.67 |
01:01 ET | 37420 | 140.91 |
01:03 ET | 16759 | 140.77 |
01:06 ET | 11272 | 140.85 |
01:08 ET | 12081 | 141.34 |
01:10 ET | 11697 | 141.615 |
01:12 ET | 13575 | 141.38 |
01:14 ET | 5729 | 141.2001 |
01:15 ET | 4178 | 141.335 |
01:17 ET | 4865 | 141.23 |
01:19 ET | 3820 | 141.14 |
01:21 ET | 3258 | 141.1 |
01:24 ET | 4536 | 141.2 |
01:26 ET | 5757 | 141.05 |
01:28 ET | 14426 | 141.1239 |
01:30 ET | 5844 | 141.1289 |
01:32 ET | 18497 | 141.6 |
01:33 ET | 3928 | 141.52 |
01:35 ET | 8804 | 141.33 |
01:37 ET | 7615 | 141.2 |
01:39 ET | 1996 | 141.2075 |
01:42 ET | 2024 | 141.28 |
01:44 ET | 20050 | 141.563 |
01:46 ET | 346482 | 141.4017 |
01:48 ET | 4771 | 141.33 |
01:50 ET | 6803 | 141.35 |
01:51 ET | 3528 | 141.42 |
01:53 ET | 5443 | 141.4904 |
01:55 ET | 3768 | 141.375 |
01:57 ET | 4388 | 141.335 |
02:00 ET | 3250 | 141.535 |
02:02 ET | 1500 | 141.555 |
02:04 ET | 3344 | 141.65 |
02:06 ET | 3034 | 141.54 |
02:08 ET | 2875 | 141.5699 |
02:09 ET | 2680 | 141.6422 |
02:11 ET | 2996 | 141.74 |
02:13 ET | 3550 | 141.71 |
02:15 ET | 7550 | 141.71 |
02:18 ET | 1000 | 141.7 |
02:20 ET | 8802 | 141.55 |
02:22 ET | 1856 | 141.573 |
02:24 ET | 7390 | 141.52 |
02:26 ET | 4748 | 141.4599 |
02:27 ET | 7971 | 141.4263 |
02:29 ET | 2797 | 141.465 |
02:31 ET | 4107 | 141.65 |
02:33 ET | 2990 | 141.785 |
02:36 ET | 1922 | 141.75 |
02:38 ET | 11801 | 141.8394 |
02:40 ET | 7262 | 141.8719 |
02:42 ET | 3662 | 141.815 |
02:44 ET | 16215 | 141.82 |
02:45 ET | 2670 | 141.8 |
02:47 ET | 4454 | 141.7315 |
02:49 ET | 3234 | 141.5 |
02:51 ET | 4580 | 141.78 |
02:54 ET | 11446 | 141.94 |
02:56 ET | 3534 | 141.88 |
02:58 ET | 3258 | 141.815 |
03:00 ET | 4061 | 141.82 |
03:02 ET | 12878 | 141.795 |
03:03 ET | 8194 | 142 |
03:05 ET | 4361 | 141.82 |
03:07 ET | 3332 | 141.91 |
03:09 ET | 4264 | 141.88 |
03:12 ET | 5163 | 141.96 |
03:14 ET | 2541 | 142.03 |
03:16 ET | 3102 | 142.18 |
03:18 ET | 14590 | 142.175 |
03:20 ET | 11256 | 142.245 |
03:21 ET | 2065 | 142.28 |
03:23 ET | 6069 | 142.3601 |
03:25 ET | 13202 | 142.562 |
03:27 ET | 6461 | 142.46 |
03:30 ET | 9295 | 142.5292 |
03:32 ET | 5882 | 142.61 |
03:34 ET | 13326 | 142.638 |
03:36 ET | 11819 | 142.95 |
03:38 ET | 7110 | 142.8 |
03:39 ET | 11362 | 142.74 |
03:41 ET | 5897 | 142.76 |
03:43 ET | 7582 | 142.7 |
03:45 ET | 8031 | 142.88 |
03:48 ET | 17421 | 143.13 |
03:50 ET | 13727 | 143.02 |
03:52 ET | 33828 | 143.19 |
03:54 ET | 30469 | 143.3404 |
03:56 ET | 34184 | 143.4934 |
03:57 ET | 39796 | 143.75 |
03:59 ET | 95043 | 143.69 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Moderna Inc | 54.0B | -9.2x | --- |
ICON PLC | 26.4B | 38.6x | +4.68% |
Biogen Inc | 33.7B | 28.4x | -18.14% |
Biontech SE | 22.0B | 178.3x | --- |
Grifols SA | 6.6B | 78.4x | --- |
Charles River Laboratories International Inc | 11.5B | 26.0x | +15.57% |
Moderna, Inc. is a biotechnology company. The Company is advancing a new class of medicines made of messenger ribonucleic acid (mRNA). It is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases, independently and with its strategic collaborators. mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane or secreted proteins that have a therapeutic or preventive benefit with the potential to address a spectrum of diseases. Its diverse development pipeline consists of 45 therapeutic and vaccine programs, nine of which are in late-stage development. Its products include COVID-19 vaccines (mRNA-1273/Spikevax, next-generation mRNA-1283), RSV vaccine (mRNA-1345), Seasonal influenza vaccines (mRNA-1010, mRNA-1011, mRNA-1012, mRNA-1020 and mRNA-1030), Combination vaccines (mRNA-1083, mRNA-1230, mRNA-1045 and mRNA-1365), CMV vaccine (mRNA-1647), EBV vaccine (mRNA-1189 and mRNA-1195) and others.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $54.0B |
---|---|
Revenue (TTM) | $5.2B |
Shares Outstanding | 383.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.54 |
EPS | $-15.66 |
Book Value | $36.27 |
P/E Ratio | -9.2x |
Price/Sales (TTM) | 10.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -99.73% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.